[The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
D000328:Adult; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000494:pharmacology*; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D008297:Male; D010418:Pentagastrin / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D010890:Pirenzepine
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D010879:Piperazines; D010890:Pirenzepine; D010418:Pentagastrin
Effet du pirenzépin (LS 519) sur la sécrétion gastrique acide basale et stimulée par la pentagastrine chez l'homme sain.